All of these results are consistent with the recently reported activity of the bifunctional MOR agonist/DOR antagonist [Nal(2′)4]CJ-15,208, which also did not produce hyperlocomotion or respiratory depression; indeed, the bifunctional peptide briefly and significantly increased respiration as well [46]. The gene discussed is OPRM1; the disease is Respiratory insufficiency due to muscle weakness.